IP Library Granted Patent US 9,375,161
Granted Patent B2
US 9,375,161 · App. 13/127,617 · Granted Jun 28, 2016

System and method for detecting cardiac arrhythmias from heart nerve activity

Inventors: Peng-Sheng Chen (Indianapolis, IN); Shien-Fong Lin (Indianapolis, IN)
Assignee: INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION
A61B5/04001A61B5/6846A61N1/3624A61N1/395
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,375,161
App. No.
13/127,617
Granted
Jun 28, 2016
Kind
B2
Abstract

A method has been developed that detects cardiac arrhythmia from intrinsic cardiac nerve signals obtained from a heart in a patient. The method includes sampling intrinsic cardiac nerve activity at a high sample rate, filtering the sampled signal with a high pass filter, comparing the filtered signal to a predetermined threshold, and initiating a therapeutic action in response to the filtered signal exceeding the predetermined threshold. The intrinsic cardiac nerve activity may be received through an electrode implanted on the heart or from an electrode inserted into the venous structure of the heart.

Claims (32)

1. A method for detecting and treating cardiac events comprising:

sampling, using an electrode positioned within a heart to receive cardiac nerve activity, intrinsic cardiac nerve activity at a high sample rate;

filtering the sampled signal with a high pass filter;

comparing the filtered signal to a predetermined threshold; and

initiating a therapeutic action in response to the filtered signal exceeding the predetermined threshold.

2. The method of claim 1 , wherein the cardiac nerve activity being sampled has a bandwidth of 1000 Hz.

3. The method of claim 1 , the sampling of the cardiac nerve activity further comprising:

sampling the cardiac nerve activity at a rate of at least 5000 samples per second.

4. The method of claim 1 , the high pass filtering of the sampled signal further comprising:

filtering the sampled signal with a high pass filter having a cutoff frequency of 300 Hz.

5. The method of claim 1 , wherein the predetermined threshold is a predetermined signal amplitude.

6. The method of claim 1 , wherein the predetermined threshold is a predetermined frequency.

7. The method of claim 1 , the therapeutic action comprising:

delivering at least one pharmacological agent to a heart.

8. The method of claim 1 , the therapeutic action comprising:

applying one of cardiac pacing, cardioversion, or defibrillation shocks to a heart.

9. The method of claim 1 , the therapeutic action comprising:

delivering carvedilol in an effective amount to a heart.

10. A system for detecting and treating cardiac events comprising:

electrodes configured to be positioned within a heart and adapted to be coupled to intrinsic cardiac nerves in the heart;

a high frequency signal sampling circuit coupled to the electrodes, the sampling circuit configured to sample intrinsic nerve signals received from the electrodes;

a high pass filter, coupled to the high frequency signal sampling circuit, having a cutoff frequency of approximately 300 Hz configured to at least filter artifacts associated with cardiac activity from the sampled intrinsic nerve signals; and

a comparator coupled to the high pass filter, the comparator comparing the filtered signals to a predetermined threshold and generating an alarm signal in response to the filtered signals exceeding the predetermined threshold.

11. The system of claim 10 , wherein the electrodes are stainless steel wires.

12. The system of claim 10 , the high frequency sampling circuit sampling the signal received from the electrodes at a rate of at least 5000 samples per second.

13. The system of claim 10 , the predetermined threshold corresponding to a predetermined amplitude.

14. The system of claim 10 , the predetermined threshold corresponding to a predetermined frequency.

15. The system of claim 10 further comprising:

a therapeutic signal generator coupled to the comparator, the therapeutic signal generator generating a therapeutic signal in response to the alarm signal.

16. The system of claim 15 , the therapeutic signal delivering at least one pharmacological agent to the heart.

17. The system of claim 16 , the therapeutic signal applying one of cardiac pacing, cardioversion, or defibrillation shocks to the heart.

18. The system of claim 16 wherein the at least one pharmacological agent includes carvedilol.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 25, 2011
From: INDIANA UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026641/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2011
From: CHEN, PENG-SHENG; LIN, SHIEN-FONG
To: INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION
Reel/Frame 026224/0719 →
Continuity (2)
Provisional Application 61112312 · Nov 7, 2008
Related Publication 20110218415A1 · Sep 8, 2011